NCT01378286View on ClinicalTrials.gov

Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Malaria
Interventions
DRUG

ARTESUNATE + AMODIAQUINE

"Pharmaceutical form:~Route of administration:"

DRUG

Chloroquine

Pharmaceutical form:tablet Route of administration: oral

Trial Locations (1)

Unknown

Administrative office, São Paulo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY